Ascorbic acid role in containment of the world avian flu pandemic

Experimental Biology and Medicine

Volumn 232, Issue 7, 2007, Pages 847-851

  Ely, John T A ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE   (New Zealand)

Author keywords

Ascorbic acid; Avian flu; Hyperglycemia; Immunity; Refined diet

Indexed keywords

ASCORBIC ACID; GLUCOSE;

AVIAN INFLUENZA; DIETARY INTAKE; DRUG UTILIZATION; HUMAN; INFECTION CONTROL; NONHUMAN; REVIEW; RISK ASSESSMENT; SURVIVAL RATE;

ANIMALS; ASCORBIC ACID; COMMUNICABLE DISEASE CONTROL; DIET; DISEASE OUTBREAKS; HUMANS; HYPERGLYCEMIA; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MODELS, BIOLOGICAL; POULTRY;

AVES;

EID: 34347386443     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Pauling LJ. How to Live Longer and Feel Better. New York: Avon Books, pp8-9, 87-88, 90, 95, 121-122, 276-277, 354-356, chapters 12 and 14, Bibliography pp368-393, 1987.
2. Stone I. The Healing Factor: Vitamin C Against Disease. New York: Grosset and Dunlap, 1972. [Full text available at http://vitamincfoundation.org/stone/]
3. Thorson A, Petzold M, Nguyen TK, Ekdahl K. Is exposure to sick or dead poultry associated with flulike illness? Arch Intern Med 166:119-123, 2006.
4. Sasazuki S, Sasaki S, Tsubono Y, Okubo S, Hayashi M, Tsugane S. Effect of vitamin C on common cold: randomized controlled trial. Eur J Clin Nutr 60:9-17, 2006.
5. Uram JA, Friedman L, Kline OL. Influence of diet on glucose tolerance. Am J Physiol 192:521-524, 1958.
6. Cohen AM, Teitelbaum A. Effect of dietary sucrose and starch on oral glucose tolerance and insulin-like activity. Am J Physiol 206:105-108, 1964.
7. Cohen AM, Teitelbaum A, Baogh M, Groen JJ. Effect of interchanging bread and sucrose as main source of carbohydrate in a low fat diet on the glucose tolerance curve of healthy volunteer subjects. Am J Clin Nutr 19:59-62, 1966.
8. Ely JTA. Hyperglycemia and major congenital anomalies. N Engl J Med 305:833, 1981.
9. Santisteban GA, Ely JTA, Hamel EE, Read DH, Kozawa SM. Glycemic modulation of tumor tolerance in a mouse model of breast cancer. Biochem Biophys Res Commun 132:1174-1179, 1985.
10. Hamel EE, Santisteban GA, Ely JTA, Read DH. Hyperglycemia and reproductive defects in non-diabetic gravidas: a mouse model test of a new theory. Life Sci 39:1425-1428, 1986.
11. Chatterjee IB, Majumder AK, Nandi BK, Subramanian N. Synthesis and some major functions of vitamin C in animals. Ann N Y Acad Sci 258:24-47, 1975.
12. Pauling LJ. Case report: lysine/ascorbate-related amelioration of angina pectoris. J Orthomol Med 6:144-146, 1991.
13. Ely JTA. Ascorbic acid and some other modern analogs of the germ theory. J Orthomol Med 14:143-156, 1999.
14. Williams RJ. Nutrition Against Disease. New York: Bantam Books, pp370, 1971.
15. Lewin S. Vitamin C: its molecular biology and medical potential. New York: Academic Press, pp231, 1976.
16. Jungeblut CW. Inactivation of poliomyelitis virus by crystalline vitamin C (ascorbic acid). J Exp Med 62:317-321, 1935.
17. King CG. Ascorbic acid (vitamin C) and scurvy. In: Williams RJ, Lansford EM, Eds. Encyclopedia of Biochemistry. New York: Reinhold Publishing, pp95-99, 1967.
18. Ely JTA. Warner GA, Read DH, Santisteban GA. Protein glycation: ascorbate antagonism [abstract]. Bull Am Phys Soc 33:296, 1988.
19. Ely JTA. Glycemic modulation of tumor tolerance. J Orthomol Med 11:23-34, 1996.
20. Ely JTA. Unrecognized pandemic subclinical diabetes of the affluent nations: causes, cost and prevention. J Orthomol Med 11:95-99, 1996.
21. Chatterjee IB, Bannerjee A. Estimation of dehydroascorbic acid in blood of diabetic patients. Anal Biochem 98:368-374 1979.
22. McCormick WJ. Ascorbic acid as a chemotherapeutic agent. Arch Pediatr 69:151-155, 1952
23. Klenner FR. The treatment of poliomyelitis and other virus diseases with vitamin C. Southern Med Surg 111:209-214, 1949.
24. Klenner FR. Observations on the dose and administration of ascorbic acid when employed beyond the range of a vitamin in human pathology. J Appl Nutr 23:61-68, 1971.
25. Klenner FR. Significance of high daily intake of ascorbic acid in preventive medicine. J Prev Med 1:45-69, 1974.
26. Cathcart RF. Vitamin C, titrating to bowel tolerance, anascorbemia, and acute induced scurvy. Med Hypotheses 7:1359-1376, 1981.
27. Hoffer A. Ascorbic acid and toxicity. N Engl J Med 285:635-636, 1971.
28. Hoffer A. Clinical procedures in treating terminally ill cancer patients with vitamin C. J Orthomol Med 6:155-160, 1991.
29. Jungeblut CW, Zwemer RL. Inactivation of diphtheria toxin in vivo and in vitro by crystalline vitamin C (ascorbic acid). Proc Soc Exp Biol Med 32:1229-1234, 1935.
30. Jungeblut CW. Inactivation of tetanus toxin by crystalline vitamin C (ascorbic acid). J Immunol 33:203-214, 1937.
31. Bartlett MK, Jones FM, Ryan AE. Vitamin C and wound healing: ascorbic acid content and tensile strength of healing wounds in human being. N Engl J Med 226:474-481, 1942
32. Crandon JH, Landau B, Mikal S, Balmanno J, Jefferson M, Mahoney N. Ascorbic acid economy in surgical patients as indicated by blood ascorbic acid levels. N Engl J Med 258:105-113, 1958.
33. Nathens AB, Neff MJ, Jurkovich GJ, Klotz P, Farver K, Ruzinski JT, Radella F, Garcia I, Maier RV. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 236:814-822, 2002.
34. WHO. World Health Report 2000-Health Systems: Improving Performance. Available at: http://www.who.int/whr/2000/en/index.html. Accessed 10 March 2007.
35. Cooper MR, McCall CE, DeChatelet LR. Stimulation of leukocyte hexose monophosphate shunt activity by ascorbic acid. Infect Immun 3:851-853, 1971.
36. Mann GV, Newton P. The membrane transport of ascorbic acid. Ann N Y Acad Sci 258:243-252, 1975.
37. Sarji KE, Kleinfelder J, Brewington P, Gonzalez J, Hempling H, Colwell JA. Decreased platelet vitamin C in diabetes mellitus: possible role in hyperaggregation. Throm Res 15:v, 639-650, 1979.
38. Hutchinson ML, Lee WYL, Chen MS, Davis KA, Ely JTA, Labbe RF. Effects of glucose and select pharmacologic agents on leukocyte ascorbic acid levels [abstract]. Fed Proc 42:930, 1983.
39. Ely JTA, Spackman DH. Hexose monophosphate shunt suppression in leukocytes and tumor cells [abstract]. Proc Am Assoc Cancer Res 24:206, 1983.
40. Cousins L. Congenital anomalies among infants of diabetic mothers: etiology, prevention, prenatal diagnosis. Am J Obstet Gynecol 147:333-338, 1983.
41. United States Department of Agriculture. Food composition database. Available at: http://www.nal.usda.gov/fnic/foodcomp/search. Accessed 28 March 2007.